Minerva Neurosciences Inc.
NERV | NASDAQ
$3.71
+$0.03 (+0.82%)
Sep 22, 2026, 10:47 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 82.3M | 21.36M | 40.91M | 36.09M | 60.76M | 25.36M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | -2.35M |
Other Long-Term Assets | n/a | n/a | n/a | n/a | -1 | 14.81K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 798K | 906.9K | 1.09M | 4.07M | 100K | 100K |
Total Current Assets | 83.1M | 22.27M | 42M | 40.16M | 62.2M | 27.44M |
Property-Plant & Equipment | n/a | 5.44K | 10.88K | 16.33K | 51.08K | 101.79K |
Goodwill & Intangibles | 14.87M | 14.87M | 14.89M | 14.91M | 14.87M | 30.07M |
Total Long-Term Assets | 14.87M | 14.87M | 14.9M | 14.93M | 14.92M | 30.19M |
Total Assets | 97.97M | 37.14M | 56.9M | 55.09M | 77.12M | 57.63M |
Account Payables | 639K | 1.61M | 1.81M | 969.67K | 1.85M | 995.61K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | -473 | 363.18K | 590.77K | 14.83K | n/a | 31.88K |
Total Current Liabilities | 2.29M | 2.84M | 3.34M | 1.38M | 2.82M | 3.16M |
Long-Term Debt | 64.96M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 171.46M | 60M | 82.02M | 73.73M | 66.33M | n/a |
Total Long-Term Liabilities | 236.43M | 60M | 82.02M | 73.73M | 66.33M | 1.8M |
Total Liabilities | 238.72M | 62.84M | 85.36M | 75.11M | 69.15M | 4.96M |
Total Debt | 64.96M | n/a | n/a | n/a | n/a | 111.23K |
Book Value | -140.75M | -25.69M | -28.46M | -20.02M | 7.98M | 52.66M |
Book Value Per Share | -16.63 | -3.39 | -4.37 | -3.75 | 1.49 | 10.30 |
Common Stock | 4.33K | 699 | 699 | 534 | 534 | 4.27K |
Retained Earnings | -688.8M | -395.38M | -396.82M | -366.81M | -334.7M | -284.8M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -140.75M | -25.69M | -28.46M | -20.02M | 7.98M | 52.66M |
Total Investments | n/a | n/a | n/a | n/a | n/a | -2.35M |
Add to Watchlist
Select watchlists to add or remove NERV